tiprankstipranks
Needham upgrades NeoGenomics to Buy amid revenue and margin growth
The Fly

Needham upgrades NeoGenomics to Buy amid revenue and margin growth

Needham analyst Mike Matson upgraded NeoGenomics to Buy from Hold with a $15 price target. The analyst is "more encouraged" by NeoGenomics’ revenue and margin growth in recent quarters amid changes to pricing and operational improvements. While management has indicated that 2023 RaDaR sales are not likely to be meaningful, the firm believes that if early adoption signs are encouraging, investor excitement could build heading into 2024.

Published first on TheFly

See Insiders’ Hot Stocks on TipRanks >>

Read More on NEO:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles